Development of Lipo-γ-AA Peptides as Potent Antifungal Agents. 2022

Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
College of Pharmaceutical Sciences, Medical Research Institute, Southwest University, Chongqing 400715, PR China.

The emergence of drug-resistant fungal pathogens poses great threats to an increasing number of vulnerable populations worldwide, and the need for novel antifungal agents is imperative. In this work, a series of lipo-γ-AA peptides were synthesized and evaluated for their biological activities. One lead, MW5, exhibited potent and broad-spectrum antifungal activity. In addition, MW5 potently boosted the efficacy of fluconazole against clinical azole-resistant Candida isolates. Mechanistic investigation showed that the lead compound disrupted the cell membrane, significantly boosted the production of reactive oxygen species, and undermined the function of the efflux pump, thus resensitizing drug-resistant Candida albicans to fluconazole. Notably, coadministration of MW5 and fluconazole exhibited potent in vivo antifungal activity in a murine model of mucocutaneous candidiasis. Our results demonstrated that lipo-γ-AA peptides have great promise for use alone or in combination to combat drug-resistant Candida infections.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D025141 Drug Resistance, Fungal The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation. Antibiotic Resistance, Fungal,Antifungal Drug Resistance,Resistance, Antifungal Drug

Related Publications

Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
May 2021, Biomaterials science,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
October 2014, Chembiochem : a European journal of chemical biology,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
January 2020, European journal of medicinal chemistry,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
April 2012, Journal of medicinal chemistry,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
January 2020, Frontiers in cellular and infection microbiology,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
July 2023, RSC medicinal chemistry,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
October 2002, Bioorganic & medicinal chemistry letters,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
May 2020, Plant physiology and biochemistry : PPB,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
July 2018, European journal of medicinal chemistry,
Xing Zhang, and Minghui Wang, and Xiaodi Zhu, and Yan Peng, and Tiwei Fu, and Chang-Hua Hu, and Jianfeng Cai, and Guojian Liao
March 2002, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!